𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitochondrial oxidative phosphorylation defects in parkinson's disease

✍ Scribed by John M. Shoffner; Ray L. Watts; Jorge L. Juncos; Antonio Torroni; Dr. Douglas C. Wallace


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
756 KB
Volume
30
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Mitochondrial function in Parkinson's di
✍ Fiorenzo Dagani; Jeffrey J. Anderson; Thomas N. Chase πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 236 KB πŸ‘ 2 views
Mitochondrial abnormalities in Parkinson
✍ Yoshikuni Mizuno; Shin-Ichirou Ikebe; Nobutaka Hattori; Yuko Nakagawa-Hattori; M πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 1 views
Mitochondrial function in Parkinson's di
✍ Prof. Anthony H. V. Schapira; Vincent M. Mann; J. Mark Cooper; David Krige; Pete πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 1000 KB
Parkinson's disease/Parkinson syndromesβ€”
πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 237 KB

Recently, it was reported that parkinsonlan patients exhibit mitochondrial abnormalhies which might be related to the production of either endogenous or exogenous toxins. We, thus, assessed possible inhibitory effects of dopamine-related compounds on mitochondrial respiration in rat brain. We found

Parkinson's syndrome and Parkinson's dis
✍ Josef Finsterer πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 168 KB

## Abstract In the majority of cases, mitochondrial disorders are multisystem conditions that most frequently affect the skeletal muscle, followed by the central nervous system. One of the clinical manifestations of central nervous system involvement is Parkinson's syndrome (PS). Evidence for an as